Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.
Identifieur interne : 000583 ( PubMed/Corpus ); précédent : 000582; suivant : 000584Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.
Auteurs : Hannah R. Doss ; Mathura Raman ; Ryan Knihtila ; Naresh Chennamsetty ; David Wang ; Alan Shupe ; Nesredin MussaSource :
- Journal of chromatography. A [ 1873-3778 ] ; 2019.
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Antibodies, Monoclonal, Immunoglobulin G.
- chemical , isolation & purification : Antibodies, Monoclonal, Immunoglobulin G.
- methods : Chemistry, Pharmaceutical.
- Chromatography, Gel, Hydrophobic and Hydrophilic Interactions, Molecular Weight.
Abstract
When developing purification processes for monoclonal antibodies (mAbs), ensuring the effective removal of high molecular weight (HMW) species is often challenging and labor intensive. In this work, we present a bottom-up characterization approach to achieve streamlined polishing step development as well as a more fundamental understanding of the protein of interest. Prior to physicochemical characterization, in-process HMW species of two IgG4 mAbs (mAb A and mAb B) were isolated via semi-preparative size exclusion chromatography (SEC). Key differences in approximate molecular weight, net charge, and native surface hydrophobicity were then identified using multi-angle light scattering (SEC-MALS), analytical-scale chromatographic screening, isoelectric focusing, and structural aggregation propensity modeling. SEC-MALS revealed two main HMW isoforms for each mAb: dimers and 1.7-mers for mAb A, and tetramers and dimers for mAb B. Analytical-scale chromatographic screening showed promising trends in charge-based separation for mAb A, and hydrophobic-based separation for mAb B. Isoelectric focusing data detected a 30% increase in acidic variants for mAb A HMW species relative to monomer, and a 20% increase in basic variants for mAb B HMW species. Lastly, analytical-scale characterization data was successfully applied to preparative scale purification conditions, producing results highly similar to those observed during analytical characterization of the isolated species. By using this high-throughput approach as a template for preparative-scale process development, key physicochemical differences between aggregate and monomer species were utilized to determine optimal polishing steps for HMW removal.
DOI: 10.1016/j.chroma.2019.03.044
PubMed: 30954243
Links to Exploration step
pubmed:30954243Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.</title>
<author><name sortKey="Doss, Hannah R" sort="Doss, Hannah R" uniqKey="Doss H" first="Hannah R" last="Doss">Hannah R. Doss</name>
<affiliation><nlm:affiliation>Biologics Manufacturing Sciences and Technology, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA; Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA. Electronic address: dossh@rpi.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Raman, Mathura" sort="Raman, Mathura" uniqKey="Raman M" first="Mathura" last="Raman">Mathura Raman</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Knihtila, Ryan" sort="Knihtila, Ryan" uniqKey="Knihtila R" first="Ryan" last="Knihtila">Ryan Knihtila</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chennamsetty, Naresh" sort="Chennamsetty, Naresh" uniqKey="Chennamsetty N" first="Naresh" last="Chennamsetty">Naresh Chennamsetty</name>
<affiliation><nlm:affiliation>Biophysics Center of Excellence, Global Product Development and Supply, Bristol-Myers Squibb Company, Pennington, NJ, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, David" sort="Wang, David" uniqKey="Wang D" first="David" last="Wang">David Wang</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shupe, Alan" sort="Shupe, Alan" uniqKey="Shupe A" first="Alan" last="Shupe">Alan Shupe</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mussa, Nesredin" sort="Mussa, Nesredin" uniqKey="Mussa N" first="Nesredin" last="Mussa">Nesredin Mussa</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30954243</idno>
<idno type="pmid">30954243</idno>
<idno type="doi">10.1016/j.chroma.2019.03.044</idno>
<idno type="wicri:Area/PubMed/Corpus">000583</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000583</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.</title>
<author><name sortKey="Doss, Hannah R" sort="Doss, Hannah R" uniqKey="Doss H" first="Hannah R" last="Doss">Hannah R. Doss</name>
<affiliation><nlm:affiliation>Biologics Manufacturing Sciences and Technology, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA; Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA. Electronic address: dossh@rpi.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Raman, Mathura" sort="Raman, Mathura" uniqKey="Raman M" first="Mathura" last="Raman">Mathura Raman</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Knihtila, Ryan" sort="Knihtila, Ryan" uniqKey="Knihtila R" first="Ryan" last="Knihtila">Ryan Knihtila</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chennamsetty, Naresh" sort="Chennamsetty, Naresh" uniqKey="Chennamsetty N" first="Naresh" last="Chennamsetty">Naresh Chennamsetty</name>
<affiliation><nlm:affiliation>Biophysics Center of Excellence, Global Product Development and Supply, Bristol-Myers Squibb Company, Pennington, NJ, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, David" sort="Wang, David" uniqKey="Wang D" first="David" last="Wang">David Wang</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shupe, Alan" sort="Shupe, Alan" uniqKey="Shupe A" first="Alan" last="Shupe">Alan Shupe</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mussa, Nesredin" sort="Mussa, Nesredin" uniqKey="Mussa N" first="Nesredin" last="Mussa">Nesredin Mussa</name>
<affiliation><nlm:affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of chromatography. A</title>
<idno type="eISSN">1873-3778</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal (chemistry)</term>
<term>Antibodies, Monoclonal (isolation & purification)</term>
<term>Chemistry, Pharmaceutical (methods)</term>
<term>Chromatography, Gel</term>
<term>Hydrophobic and Hydrophilic Interactions</term>
<term>Immunoglobulin G (chemistry)</term>
<term>Immunoglobulin G (isolation & purification)</term>
<term>Molecular Weight</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Chemistry, Pharmaceutical</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Chromatography, Gel</term>
<term>Hydrophobic and Hydrophilic Interactions</term>
<term>Molecular Weight</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">When developing purification processes for monoclonal antibodies (mAbs), ensuring the effective removal of high molecular weight (HMW) species is often challenging and labor intensive. In this work, we present a bottom-up characterization approach to achieve streamlined polishing step development as well as a more fundamental understanding of the protein of interest. Prior to physicochemical characterization, in-process HMW species of two IgG4 mAbs (mAb A and mAb B) were isolated via semi-preparative size exclusion chromatography (SEC). Key differences in approximate molecular weight, net charge, and native surface hydrophobicity were then identified using multi-angle light scattering (SEC-MALS), analytical-scale chromatographic screening, isoelectric focusing, and structural aggregation propensity modeling. SEC-MALS revealed two main HMW isoforms for each mAb: dimers and 1.7-mers for mAb A, and tetramers and dimers for mAb B. Analytical-scale chromatographic screening showed promising trends in charge-based separation for mAb A, and hydrophobic-based separation for mAb B. Isoelectric focusing data detected a 30% increase in acidic variants for mAb A HMW species relative to monomer, and a 20% increase in basic variants for mAb B HMW species. Lastly, analytical-scale characterization data was successfully applied to preparative scale purification conditions, producing results highly similar to those observed during analytical characterization of the isolated species. By using this high-throughput approach as a template for preparative-scale process development, key physicochemical differences between aggregate and monomer species were utilized to determine optimal polishing steps for HMW removal.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30954243</PMID>
<DateCompleted><Year>2019</Year>
<Month>07</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>07</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3778</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>1598</Volume>
<PubDate><Year>2019</Year>
<Month>Aug</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>Journal of chromatography. A</Title>
<ISOAbbreviation>J Chromatogr A</ISOAbbreviation>
</Journal>
<ArticleTitle>Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.</ArticleTitle>
<Pagination><MedlinePgn>101-112</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0021-9673(19)30312-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chroma.2019.03.044</ELocationID>
<Abstract><AbstractText>When developing purification processes for monoclonal antibodies (mAbs), ensuring the effective removal of high molecular weight (HMW) species is often challenging and labor intensive. In this work, we present a bottom-up characterization approach to achieve streamlined polishing step development as well as a more fundamental understanding of the protein of interest. Prior to physicochemical characterization, in-process HMW species of two IgG4 mAbs (mAb A and mAb B) were isolated via semi-preparative size exclusion chromatography (SEC). Key differences in approximate molecular weight, net charge, and native surface hydrophobicity were then identified using multi-angle light scattering (SEC-MALS), analytical-scale chromatographic screening, isoelectric focusing, and structural aggregation propensity modeling. SEC-MALS revealed two main HMW isoforms for each mAb: dimers and 1.7-mers for mAb A, and tetramers and dimers for mAb B. Analytical-scale chromatographic screening showed promising trends in charge-based separation for mAb A, and hydrophobic-based separation for mAb B. Isoelectric focusing data detected a 30% increase in acidic variants for mAb A HMW species relative to monomer, and a 20% increase in basic variants for mAb B HMW species. Lastly, analytical-scale characterization data was successfully applied to preparative scale purification conditions, producing results highly similar to those observed during analytical characterization of the isolated species. By using this high-throughput approach as a template for preparative-scale process development, key physicochemical differences between aggregate and monomer species were utilized to determine optimal polishing steps for HMW removal.</AbstractText>
<CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doss</LastName>
<ForeName>Hannah R</ForeName>
<Initials>HR</Initials>
<AffiliationInfo><Affiliation>Biologics Manufacturing Sciences and Technology, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA; Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA. Electronic address: dossh@rpi.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Raman</LastName>
<ForeName>Mathura</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Knihtila</LastName>
<ForeName>Ryan</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chennamsetty</LastName>
<ForeName>Naresh</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Biophysics Center of Excellence, Global Product Development and Supply, Bristol-Myers Squibb Company, Pennington, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shupe</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mussa</LastName>
<ForeName>Nesredin</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Biologics Process Development, Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>03</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>J Chromatogr A</MedlineTA>
<NlmUniqueID>9318488</NlmUniqueID>
<ISSNLinking>0021-9673</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002850" MajorTopicYN="N">Chromatography, Gel</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057927" MajorTopicYN="N">Hydrophobic and Hydrophilic Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Analytical-scale chromatographic screening</Keyword>
<Keyword MajorTopicYN="N">Isoelectric focusing</Keyword>
<Keyword MajorTopicYN="N">Monoclonal antibody aggregate characterization</Keyword>
<Keyword MajorTopicYN="N">Process development enhancement</Keyword>
<Keyword MajorTopicYN="N">SEC-MALS</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year>
<Month>11</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2019</Year>
<Month>03</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2019</Year>
<Month>03</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>4</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>7</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>4</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30954243</ArticleId>
<ArticleId IdType="pii">S0021-9673(19)30312-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.chroma.2019.03.044</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:30954243 |texte= Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:30954243" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |